New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Mouse model may help explain and treat infertility

Mouse model may help explain and treat infertility

by Sherrie Negrea,Cornell UniversityDesign and validation of the mouse line expressing Acr-GCaMP3er-mCherry (Acrosome-targeted Sensor for Exocytosis [AcroSensE]). A, schematic of the construct.
Reproduction May 09,2024
Mouse model may help explain and treat infertility

Mouse model may help explain and treat infertility

by Sherrie Negrea,Cornell UniversityDesign and validation of the mouse line expressing Acr-GCaMP3er-mCherry (Acrosome-targeted Sensor for Exocytosis [AcroSensE]). A, schematic of the construct.
Reproduction May 09,2024
New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

by Gillian Rutherford,University of AlbertaWnt/β-catenin pathway inhibitors enhance induction of type I and III interferons in response to viral infection. A549 cells were treated with DMSO alon
Public Health & Prevention May 09,2024
New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

by Gillian Rutherford,University of AlbertaWnt/β-catenin pathway inhibitors enhance induction of type I and III interferons in response to viral infection. A549 cells were treated with DMSO alon
Public Health & Prevention May 09,2024
Novel drug combination shows promise for advanced HER2-negative breast cancer

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a
Oncology May 09,2024
Novel drug combination shows promise for advanced HER2-negative breast cancer

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a
Oncology May 09,2024
Clinical trial shows rheumatoid arthritis drug could prevent disease

Clinical trial shows rheumatoid arthritis drug could prevent disease

by King's College LondonCredit: Unsplash/CC0 Public DomainA drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk. Results from a Phase 2b
Breakthroughs May 09,2024
Clinical trial shows rheumatoid arthritis drug could prevent disease

Clinical trial shows rheumatoid arthritis drug could prevent disease

by King's College LondonCredit: Unsplash/CC0 Public DomainA drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk. Results from a Phase 2b
Breakthroughs May 09,2024
New insulin mixture could make life easier for patients with type 1 diabetes

New insulin mixture could make life easier for patients with type 1 diabetes

by Sølvi Normannsen,Norwegian University of Science and TechnologyTests show that MicroGlucagon (orange curve) works faster and is more effective than the fastest-acting insulins on the market (
Diabetes & Endocrinology May 09,2024
New insulin mixture could make life easier for patients with type 1 diabetes

New insulin mixture could make life easier for patients with type 1 diabetes

by Sølvi Normannsen,Norwegian University of Science and TechnologyTests show that MicroGlucagon (orange curve) works faster and is more effective than the fastest-acting insulins on the market (
Diabetes & Endocrinology May 09,2024
Study finds tafenoquine is a cost-effective treatment option for malaria

Study finds tafenoquine is a cost-effective treatment option for malaria

by Menzies School of Health ResearchMap of incremental cost-effectiveness ratios (ICERs) in each malaria-endemic municipality for Scenario 1 (tafenoquine for adults, primaquine adherence 66.7%),
Breakthroughs May 09,2024
Study finds tafenoquine is a cost-effective treatment option for malaria

Study finds tafenoquine is a cost-effective treatment option for malaria

by Menzies School of Health ResearchMap of incremental cost-effectiveness ratios (ICERs) in each malaria-endemic municipality for Scenario 1 (tafenoquine for adults, primaquine adherence 66.7%),
Breakthroughs May 09,2024
Dexmedetomidine cuts incidence of postpartum depression after C-section

Dexmedetomidine cuts incidence of postpartum depression after C-section

by Elana GotkineFor women with prenatal depression undergoing cesarean delivery, dexmedetomidine reduces the incidence of positive postpartum depression (PPD) screening, according to a studypubl
Breakthroughs May 09,2024
Dexmedetomidine cuts incidence of postpartum depression after C-section

Dexmedetomidine cuts incidence of postpartum depression after C-section

by Elana GotkineFor women with prenatal depression undergoing cesarean delivery, dexmedetomidine reduces the incidence of positive postpartum depression (PPD) screening, according to a studypubl
Breakthroughs May 09,2024
Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha
Oncology May 09,2024
Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha
Oncology May 09,2024
Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung
Oncology May 09,2024
Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung
Oncology May 09,2024
Want safer prescribing? Provide doctors with a plan for helping patients in pain, says study

Want safer prescribing? Provide doctors with a plan for helping patients in pain, says study

by University of Southern CaliforniaClinician-level Opioid Prescribing. Boxplots showing median logMME, the interquartile range, and outliers pre-to-post intervention between study arms amo
Breakthroughs May 09,2024
Want safer prescribing? Provide doctors with a plan for helping patients in pain, says study

Want safer prescribing? Provide doctors with a plan for helping patients in pain, says study

by University of Southern CaliforniaClinician-level Opioid Prescribing. Boxplots showing median logMME, the interquartile range, and outliers pre-to-post intervention between study arms amo
Breakthroughs May 09,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com